Search

Your search keyword '"Han, Zhigang"' showing total 54 results

Search Constraints

Start Over You searched for: Author "Han, Zhigang" Remove constraint Author: "Han, Zhigang" Publisher elsevier bv Remove constraint Publisher: elsevier bv
54 results on '"Han, Zhigang"'

Search Results

1. Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial

4. Interactions between endophytic fungus Pestalotiopsis sp. DO14 and Dendrobium catenatum: Deciphering plant polysaccharide and flavonoid accumulation and underlying mechanisms by comparative transcriptome and metabolome analyses

6. Machine learning uncovers accumulation mechanism of flavonoid compounds in Polygonatum cyrtonema Hua

7. Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies

9. Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study

12. Central Nervous System Efficacy of Rezivertinib (BPI-7711) in Advanced NCLC Patients with EGFR T790m Mutation: A Pooled Analysis of Two Clinical Trials

14. Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study

15. Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring MET Exon 14 Skipping Alterations

17. Efficacy and Safety of Rezivertinib (BPI-7711) in Patients with Locally Advanced or Metastatic/Recurrent EGFR T790M Mutated NSCLC: A Phase IIb Study

19. Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study

21. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

27. Hysteretic effects of meteorological conditions and their interactions on particulate matter in Chinese cities

29. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

37. Fog Detection over China’s Adjacent Sea Area by using the MTSAT Geostationary Satellite Data

47. ATTENUATED RESPONSE OF LIPID PLAQUE TO CHOLESTEROL LOWERING THERAPY IN DIABETIC PATIENT: AN OPTICAL COHERENCE TOMOGRAPHY STUDY

50. CORONARY PLAQUE CHARACTERISTICS IN PATIENTS WITH DIABETES MELLITUS WHO PRESENTED WITH ACUTE CORONARY SYNDROME:OPTICAL COHERENCE TOMOGRAPHY STUDY

Catalog

Books, media, physical & digital resources